Understanding how misfolded proteins behave in diseases like Alzheimer's and Parkinson's.

Identifying differences in dynamics and residual structure of intrinsically disordered domains between monomer and fibers: using alpha-synuclein as a model

NIH-funded research University of Southern California · NIH-11002690

This study is looking at how a specific protein related to diseases like Alzheimer's and Parkinson's changes shape and behavior when it misfolds, with the hope that understanding these changes will help find better treatments for patients.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Southern California NIH-funded
Lab location1 site (Los Angeles, UNITED STATES)
Project IDNIH-11002690 on NIH RePORTER

What this research studies

This research investigates the differences in the structure and behavior of misfolded proteins, specifically focusing on alpha-synuclein, which is linked to neurodegenerative diseases such as Alzheimer's and Parkinson's. By examining how these proteins change from their normal form to toxic aggregates, the study aims to uncover the role of flexible regions in these proteins that may influence their harmful effects. The approach involves advanced techniques to visualize and analyze these protein structures, which could lead to a better understanding of their impact on disease progression. Patients may benefit from insights gained that could inform future treatments targeting these misfolded proteins.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with neurodegenerative diseases such as Alzheimer's or Parkinson's.

Not a fit: Patients with neurodegenerative diseases not associated with misfolded proteins may not receive benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating neurodegenerative diseases by targeting the mechanisms of protein misfolding.

How similar studies have performed: Previous research has shown promising results in understanding protein misfolding in neurodegenerative diseases, indicating that this approach could yield valuable insights.

Where this research is happening

Los Angeles, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.